HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
SASH1
SAM and SH3 domain containing 1
Chromosome 6 Β· 6q24.3-q25.1
NCBI Gene: 23328Ensembl: ENSG00000111961.20HGNC: HGNC:19182UniProt: O94885
84PubMed Papers
22Diseases
0Drugs
14Pathogenic Variants
FUNCTIONAL ROLE
Tumor Suppressor
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein polyubiquitinationpositive regulation of endothelial cell migrationpositive regulation of lipopolysaccharide-mediated signaling pathwaypositive regulation of JUN kinase activityDyschromatosis universalispigmentation defects-palmoplantar keratoderma-skin carcinoma syndromehypothyroidismopen-angle glaucoma
✦AI Summary

SASH1 (SAM and SH3 domain containing 1) is a multifunctional scaffold protein that plays crucial roles in cellular signaling, melanocyte biology, and tumor suppression. SASH1 functions as a positive regulator of NF-ΞΊB signaling by assembling molecular complexes containing TRAF6, MAP3K7, CHUK, and IKBKB, facilitating NF-ΞΊB activation downstream of TLR4 1. The protein regulates cellular mobility, including LPS-induced endothelial cell migration and melanocyte migration in skin pigmentation control 12. SASH1 promotes melanocyte stem cell maintenance through interaction with tankyrase 2 (TNKS2), with mutations like S519N causing defects in this function and leading to accelerated hair graying and skin dyspigmentation 3. Disease-wise, SASH1 mutations are associated with dyschromatosis universalis hereditaria, causing hyper- and hypopigmented macules 4. SASH1 acts as a tumor suppressor, with reduced expression observed in various cancers including head and neck squamous cell carcinoma and cutaneous squamous cell carcinoma, where it suppresses proliferation and invasion through Akt pathway inhibition 56. Additionally, SASH1 is involved in pregnancy-related disorders, with increased expression in preeclampsia affecting trophoblast function 7.

Sources cited
1
SASH1 functions as scaffold for NF-ΞΊB signaling and regulates cellular migration
PMID: 23776175
2
SASH1 interacts with TNKS2 to maintain melanocyte stem cells, with S519N variant causing pigmentation defects
PMID: 37808724
3
SASH1 acts as prognostic biomarker and is downregulated in head and neck squamous cell carcinoma
PMID: 41099090
4
SASH1 suppresses proliferation and invasion in cutaneous squamous cell carcinoma via Akt pathway inhibition
PMID: 32547092
5
SASH1 mutations cause dyschromatosis universalis hereditaria and other pigmentation disorders
PMID: 40511878
6
SASH1 is upregulated in preeclampsia and affects trophoblast cell function
PMID: 33134379
7
SASH1 regulates melanocyte migration in skin pigmentation control
PMID: 23333244
Disease Associationsβ“˜22
Dyschromatosis universalisOpen Targets
0.75Strong
pigmentation defects-palmoplantar keratoderma-skin carcinoma syndromeOpen Targets
0.48Moderate
hypothyroidismOpen Targets
0.44Moderate
open-angle glaucomaOpen Targets
0.40Moderate
glaucomaOpen Targets
0.40Weak
thyroid diseaseOpen Targets
0.39Weak
cardiovascular diseaseOpen Targets
0.39Weak
myxedemaOpen Targets
0.37Weak
familial generalized lentiginosisOpen Targets
0.37Weak
kidney transplantOpen Targets
0.29Weak
acute cystitisOpen Targets
0.29Weak
concussionOpen Targets
0.29Weak
neurodegenerative diseaseOpen Targets
0.29Weak
Abruptio PlacentaeOpen Targets
0.27Weak
Palmoplantar keratodermaOpen Targets
0.26Weak
autoimmune diseaseOpen Targets
0.26Weak
alopeciaOpen Targets
0.26Weak
poisoningOpen Targets
0.26Weak
ankylosing spondylitisOpen Targets
0.21Weak
autoimmune thyroid diseaseOpen Targets
0.21Weak
Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratodermaUniProt
Dyschromatosis universalis hereditaria 1UniProt
Pathogenic Variants14
NM_015278.5(SASH1):c.1592C>G (p.Ser531Cys)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 531
NM_015278.5(SASH1):c.1546A>C (p.Ser516Arg)Likely pathogenic
Dyschromatosis universalis hereditaria 1
β˜…β˜†β˜†β˜†2023β†’ Residue 516
NM_015278.5(SASH1):c.1930C>T (p.Arg644Trp)Likely pathogenic
Dyschromatosis universalis hereditaria 1
β˜…β˜†β˜†β˜†2023β†’ Residue 644
NM_015278.5(SASH1):c.1574C>T (p.Thr525Ile)Likely pathogenic
Dyschromatosis universalis hereditaria 1
β˜…β˜†β˜†β˜†2023β†’ Residue 525
NM_015278.5(SASH1):c.1548T>A (p.Ser516Arg)Likely pathogenic
Dyschromatosis universalis hereditaria 1
β˜…β˜†β˜†β˜†2023β†’ Residue 516
NM_015278.5(SASH1):c.1811C>A (p.Thr604Lys)Likely pathogenic
Dyschromatosis universalis hereditaria 1
β˜…β˜†β˜†β˜†2023β†’ Residue 604
NM_015278.5(SASH1):c.1651T>G (p.Tyr551Asp)Likely pathogenic
Dyschromatosis universalis hereditaria 1
β˜…β˜†β˜†β˜†2019β†’ Residue 551
NM_015278.5(SASH1):c.1544T>C (p.Leu515Pro)Likely pathogenic
Dyschromatosis universalis hereditaria 1
β˜…β˜†β˜†β˜†2019β†’ Residue 515
NM_015278.5(SASH1):c.1525G>A (p.Glu509Lys)Likely pathogenic
Dyschromatosis universalis hereditaria 1
β˜…β˜†β˜†β˜†2019β†’ Residue 509
NM_015278.5(SASH1):c.1556G>A (p.Ser519Asn)Likely pathogenic
Dyschromatosis universalis hereditaria 1
β˜…β˜†β˜†β˜†2019β†’ Residue 519
NM_015278.5(SASH1):c.1519T>G (p.Ser507Ala)Likely pathogenic
Dyschromatosis universalis hereditaria 1
β˜…β˜†β˜†β˜†2019β†’ Residue 507
NM_015278.5(SASH1):c.1651T>C (p.Tyr551His)Likely pathogenic
Dyschromatosis universalis hereditaria 1
β˜…β˜†β˜†β˜†2019β†’ Residue 551
NM_015278.5(SASH1):c.1527_1530dup (p.Leu511fs)Pathogenic
Dyschromatosis universalis hereditaria 1
β˜†β˜†β˜†β˜†2019β†’ Residue 511
NM_015278.5(SASH1):c.1849G>A (p.Glu617Lys)Pathogenic
dyschromatosis;Ungual dystrophy;spino-cellular carcinoma;Alopecia;Palmoplantar keratoderma|Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma
β˜†β˜†β˜†β˜†2015β†’ Residue 617
View on ClinVar β†—
Related Genes
SAMD5Protein interaction94%ANXA3Shared pathway18%EMC10Shared pathway18%RBCK1Shared pathway15%MAP3K4Shared pathway15%SMOC2Shared pathway14%
Tissue Expression6 tissues
Lung
100%
Heart
99%
Brain
93%
Liver
26%
Ovary
24%
Bone Marrow
3%
Gene Interaction Network
Click a node to explore
SASH1SAMD5ANXA3EMC10RBCK1MAP3K4SMOC2
PROTEIN STRUCTURE
Preparing viewer…
PDB2DL0 Β· NMR
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.41Moderately Constrained
pLIβ“˜
1.00Intolerant
Observed/Expected LoF0.31 [0.23–0.41]
RankingsWhere SASH1 stands among ~20K protein-coding genes
  • #5,696of 20,598
    Most Researched84
  • #2,512of 5,498
    Most Pathogenic Variants14
  • #2,129of 17,882
    Most Constrained (LOEUF)0.41 Β· top quartile
Genes detectedSASH1
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
A multi-omics pipeline integrating machine learning and spatial-cellular analysis identifies SASH1 as a prognostic biomarker and therapeutic target in head and neck squamous cell carcinoma.
PMID: 41099090
Int J Surg Β· 2025
1.00
2
SASH1 interacts with TNKS2 and promotes human melanocyte stem cell maintenance.
PMID: 37808724
bioRxiv Β· 2023
0.90
3
Single-cell RNA sequencing reveals the transcriptomic landscape of kidneys in patients with ischemic acute kidney injury.
PMID: 37083129
Chin Med J (Engl) Β· 2023
0.80
4
Expression of SASH1 in Preeclampsia and Its Effects on Human Trophoblast.
PMID: 33134379
Biomed Res Int Β· 2020
0.70
5
SASH1 Mutations and Hereditary Disorders of Pigmentation: Review of Literature.
PMID: 40511878
Pigment Cell Melanoma Res Β· 2025
0.60